165 related articles for article (PubMed ID: 30142312)
1. Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis.
Altinoz MA; Bilir A; Elmaci İ
Chem Biol Interact; 2018 Oct; 294():107-117. PubMed ID: 30142312
[TBL] [Abstract][Full Text] [Related]
2. PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism.
Altinoz MA; Ozpinar A
Int Immunopharmacol; 2019 Apr; 69():245-256. PubMed ID: 30738994
[TBL] [Abstract][Full Text] [Related]
3. Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.
Altinoz MA; Ozpinar A; Ozpinar A; Hacker E
Metab Brain Dis; 2020 Jan; 35(1):1-9. PubMed ID: 31625071
[TBL] [Abstract][Full Text] [Related]
4. Effects of Lorenzo's Oil on peroxisomes in healthy mice.
De Craemer D; Van den Branden C; Fontaine M; Vamecq J
Prostaglandins Other Lipid Mediat; 1998 Mar; 55(4):237-44. PubMed ID: 9644114
[TBL] [Abstract][Full Text] [Related]
5. PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease.
Altinoz MA; Elmaci İ; Hacimuftuoglu A; Ozpinar A; Hacker E; Ozpinar A
Mol Aspects Med; 2021 Apr; 78():100871. PubMed ID: 32703610
[TBL] [Abstract][Full Text] [Related]
6. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
Rasmussen M; Moser AB; Borel J; Khangoora S; Moser HW
Neurochem Res; 1994 Aug; 19(8):1073-82. PubMed ID: 7800117
[TBL] [Abstract][Full Text] [Related]
7. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
Sassa T; Wakashima T; Ohno Y; Kihara A
J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
[TBL] [Abstract][Full Text] [Related]
8. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
[TBL] [Abstract][Full Text] [Related]
9. From epidemiology to treatment: Aspirin's prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid.
Altinoz MA; Elmaci I; Cengiz S; Emekli-Alturfan E; Ozpinar A
Chem Biol Interact; 2018 Aug; 291():29-39. PubMed ID: 29885857
[TBL] [Abstract][Full Text] [Related]
10. Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6.
Wang J; Yao L; Wu X; Guo Q; Sun S; Li J; Shi G; Caldwell RB; Caldwell RW; Chen Y
Oxid Med Cell Longev; 2021; 2021():6628957. PubMed ID: 33824696
[TBL] [Abstract][Full Text] [Related]
11. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV
Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218
[TBL] [Abstract][Full Text] [Related]
12. A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.
Basu C; Ahmed MA; Kartha RV; Brundage RC; Raymond GV; Cloyd JC; Carlin BP
J Biopharm Stat; 2016; 26(6):1025-1039. PubMed ID: 27547896
[TBL] [Abstract][Full Text] [Related]
13. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
[TBL] [Abstract][Full Text] [Related]
14. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
[TBL] [Abstract][Full Text] [Related]
16. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol in glioma treatment alone and with imatinib in vitro.
Erguven M; Yazihan N; Aktas E; Sabanci A; Li CJ; Oktem G; Bilir A
Int J Oncol; 2010 Apr; 36(4):857-66. PubMed ID: 20198329
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
19. Mutant fruit flies respond to Lorenzo's oil.
Barinaga M
Science; 1999 Jun; 284(5422):1899, 1901. PubMed ID: 10400528
[No Abstract] [Full Text] [Related]
20. Review of the potential pharmacological role of erucic acid: a monounsaturated omega-9 fatty acid.
Kazmi I; Afzal M; Al-Abbasi FA; AlGhamdi SA; Alghamdi AM; Alzarea SI; Almalki WH; AlGhamdi AS; Alkinani KB; Sayyed N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3663-3674. PubMed ID: 38060041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]